DeepCure is a company that specializes in AI-based drug discovery for small molecule therapeutics. It develops PocketExpander, a tool for discovering novel binding nodes, as well as MolGen, a molecular generation tool for creating synthesizable compounds. The company focuses on drug development for treating rheumatoid arthritis, hidradenitis suppurativa, Still's disease, asthma, atopic dermatitis, and other diseases.